8Centers for Disease Control and Prevention:Prevention and control of influenza:Recommendations of the Advisory Committee on Immunization Practices.MMWR2002,51(RR-3):1-32
9Draft WHO guidelines on the use of vaccines and antivirals during inFluenza pandemics. Wkly Epidemiol Rec. 2002,77:394-404
10Kunzel W, Glathe H, Engelmann H, et al. Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine, 1996,14:1108-1110
二级参考文献35
1[1]CDC.Prevention and control of influenza:recommendations of the Advisory Committee on Immunization Pratices (ACIP)[J].MMWR,1999,48(RR-04):1.
2[2]Neuzil KM,Reed GW,Mitchel EF,et al.Influenza-associated morbidity and mortality in young and middle-aged women[J].JAMA,1999,281:901.
4[4]Kunzel W,Glathe H,Engelmann H,et al.Kinetics of humoral antibody response to trivlent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time[J].Vaccine,1996,14:1108.
5[5]CDC.General recommendations on immunization:recommendations of the Adisory Committee on Immunization Pratices(ACIP)[J].MMWR,1996,43(RR-1):1.
6[6]Nichol KL,Margolis KL,Lind A,et al.Side effects associated with influenza vaccination in healthy working adults:a radomized,placebo-controlled trial[J].Arch Intern Med,1996,156:1546.
7[7]Bierman CW,Shapiro GG,Pierson WE,et al.Safety of influenza vaccination in allergic children[J].J Infect Dis,1997,136:S652.
8[8]James JM,Zeiger RS,Lester MR,et al.Safe administration of influenza vaccine to patients with egg allergy[J].J Pediatr,1998,133:624.
9[9]Barohn RJ,Saperstein DS.Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy[J].Semin Neurol,1998,18:49.
10[10]Jacobs BC,Rothbart PH,van der Meche FG,et al.The spectrum of antecedent infections in Guillain-Barre syndrome:a case-control study[J].Neurology,1998,51:1110.
